Complications of Antenatal Corticosteroids in Infants Born by Early Term Scheduled Cesarean Section
© 2020 by the American Diabetes Association..
OBJECTIVE: To compare neonatal hypoglycemia and respiratory morbidity rates in pregnancies complicated by diabetes following early term scheduled cesarean section (ETSCS) with and without maternal corticosteroid administration.
RESEARCH DESIGN AND METHODS: In a retrospective cohort study, women with any form of diabetes in pregnancy undergoing ETSCS were included. Primary outcomes were admission rates to the neonatal intensive care unit (NICU) for respiratory distress syndrome (RDS)/transient tachypnea of the newborn (TTN) and/or neonatal hypoglycemia.
RESULTS: NICU admission rates for neonatal hypoglycemia were significantly higher (24.2% vs. 4.4%, P = 0.003) and RDS/TTN rates were nonsignificantly higher (15.2% vs. 7.2%, P = 0.209) following corticosteroid administration.
CONCLUSIONS: Corticosteroids were not beneficial among women with any form of diabetes in pregnancy undergoing ETSCS and, indeed, may be harmful. In our hospital, we have ceased the use of corticosteroids for women under these circumstances.
Errataetall: |
ErratumIn: Diabetes Care. 2022 Apr 1;45(4):1025. - PMID 35061878 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
---|---|
Enthalten in: |
Diabetes care - 43(2020), 4 vom: 05. Apr., Seite 906-908 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gupta, Katharine [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 01.01.2021 Date Revised 29.03.2022 published: Print-Electronic ErratumIn: Diabetes Care. 2022 Apr 1;45(4):1025. - PMID 35061878 Citation Status MEDLINE |
---|
doi: |
10.2337/dc19-2126 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM30571242X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM30571242X | ||
003 | DE-627 | ||
005 | 20231225121759.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2337/dc19-2126 |2 doi | |
028 | 5 | 2 | |a pubmed24n1019.xml |
035 | |a (DE-627)NLM30571242X | ||
035 | |a (NLM)31974101 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gupta, Katharine |e verfasserin |4 aut | |
245 | 1 | 0 | |a Complications of Antenatal Corticosteroids in Infants Born by Early Term Scheduled Cesarean Section |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.01.2021 | ||
500 | |a Date Revised 29.03.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a ErratumIn: Diabetes Care. 2022 Apr 1;45(4):1025. - PMID 35061878 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2020 by the American Diabetes Association. | ||
520 | |a OBJECTIVE: To compare neonatal hypoglycemia and respiratory morbidity rates in pregnancies complicated by diabetes following early term scheduled cesarean section (ETSCS) with and without maternal corticosteroid administration | ||
520 | |a RESEARCH DESIGN AND METHODS: In a retrospective cohort study, women with any form of diabetes in pregnancy undergoing ETSCS were included. Primary outcomes were admission rates to the neonatal intensive care unit (NICU) for respiratory distress syndrome (RDS)/transient tachypnea of the newborn (TTN) and/or neonatal hypoglycemia | ||
520 | |a RESULTS: NICU admission rates for neonatal hypoglycemia were significantly higher (24.2% vs. 4.4%, P = 0.003) and RDS/TTN rates were nonsignificantly higher (15.2% vs. 7.2%, P = 0.209) following corticosteroid administration | ||
520 | |a CONCLUSIONS: Corticosteroids were not beneficial among women with any form of diabetes in pregnancy undergoing ETSCS and, indeed, may be harmful. In our hospital, we have ceased the use of corticosteroids for women under these circumstances | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
700 | 1 | |a Rajagopal, Rohit |e verfasserin |4 aut | |
700 | 1 | |a King, Felicia |e verfasserin |4 aut | |
700 | 1 | |a Simmons, David |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diabetes care |d 1979 |g 43(2020), 4 vom: 05. Apr., Seite 906-908 |w (DE-627)NLM00042983X |x 1935-5548 |7 nnns |
773 | 1 | 8 | |g volume:43 |g year:2020 |g number:4 |g day:05 |g month:04 |g pages:906-908 |
856 | 4 | 0 | |u http://dx.doi.org/10.2337/dc19-2126 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 43 |j 2020 |e 4 |b 05 |c 04 |h 906-908 |